IL1RL1 and cancer: ST2L is a transmembrane form and is expressed in a variety of cell types, including Th2 lymphocytes, macrophages and NK cells [7–9], whereas sST2 is a soluble form that is predominantly expressed in fibroblasts, epithelial cells and cancer cells [10, 11].